ID: ALA204110

Max Phase: Preclinical

Molecular Formula: C9H14N2OS

Molecular Weight: 198.29

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1c(O)nsc1C1CCNCC1

Standard InChI:  InChI=1S/C9H14N2OS/c1-6-8(13-11-9(6)12)7-2-4-10-5-3-7/h7,10H,2-5H2,1H3,(H,11,12)

Standard InChI Key:  TVYLWJFICSYNFD-UHFFFAOYSA-N

Associated Targets(Human)

GABA-A receptor; alpha-1/beta-3/gamma-2 1565 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

GABA A receptor alpha-5/beta-3/gamma-2 149 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 198.29Molecular Weight (Monoisotopic): 198.0827AlogP: 1.62#Rotatable Bonds: 1
Polar Surface Area: 45.15Molecular Species: ZWITTERIONHBA: 4HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 3.06CX Basic pKa: 9.93CX LogP: 1.34CX LogD: 1.34
Aromatic Rings: 1Heavy Atoms: 13QED Weighted: 0.72Np Likeness Score: -0.46

References

1. Krehan D, Storustovu SI, Liljefors T, Ebert B, Nielsen B, Krogsgaard-Larsen P, Frølund B..  (2006)  Potent 4-arylalkyl-substituted 3-isothiazolol GABA(A) competitive/noncompetitive antagonists: synthesis and pharmacology.,  49  (4): [PMID:16480274] [10.1021/jm050987l]

Source